DeSimone Daniel C, Garrigos Zerelda Esquer, Marx Grace E, Tattevin Pierre, Hasse Barbara, McCormick David W, Hannan Margaret M, Zuhlke Liesl J, Radke Connie S, Baddour Larry M
J Am Heart Assoc. 2025 Apr 15;14(8):e040218. doi: 10.1161/JAHA.124.040218. Epub 2025 Mar 17.
Blood culture-negative endocarditis has been associated with worse outcomes when compared with blood culture-positive endocarditis, because pathogen-directed antimicrobial therapy and other management aspects have been difficult to achieve. Novel diagnostic tools, however, have changed the landscape of this syndrome and will likely improve patient outcomes. This American Heart Association scientific statement highlights these advances. The writing group, which represents a multidisciplinary team, provides an update on blood culture-negative endocarditis. Clinical scenarios representative of real-world experiences are included to assist frontline clinicians in the diagnosis and management of this syndrome.
与血培养阳性的心内膜炎相比,血培养阴性的心内膜炎与更差的预后相关,因为针对病原体的抗菌治疗和其他管理方面一直难以实现。然而,新型诊断工具已经改变了这种综合征的局面,并可能改善患者的预后。美国心脏协会的这份科学声明强调了这些进展。代表多学科团队的写作小组提供了关于血培养阴性的心内膜炎的最新情况。文中纳入了代表现实世界经验的临床案例,以帮助一线临床医生对该综合征进行诊断和管理。